De aandelen van vaccinproducenten Moderna (NASDAQ: MRNA) en Novavax lieten woensdag in de vroege handel lichte dalingen zien, waarbij Moderna 1% daalde en Novavax 1,3% inleverde. Dit volgt op een ...

Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...

Workers who received Novavax reported 12.5% fewer local reactions than those who received the Pfizer vaccine. Average hours ...

Specifiek meldde 43,8% van de Pfizer-BioNTech-ontvangers ten minste één symptoom van graad 2 of hoger, vergeleken met 24,2% van degenen die met het Novavax-product werden gevaccineerd. Bovendien ...

Novavax (NVAX) closed the most recent trading day at $6.39, moving -0.31% from the previous trading session. This move lagged the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a ...

Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...